Related Experiment Video
Updated: Aug 29, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Pharmacodynamics and clinical use of anti-HIV drugs
Sandra L Preston1, Peter J Piliero, George L Drusano
1Clinical Research Institute, Division of Clinical Pharmacology, Albany Medical College, 47 New Scotland Avenue, mc142, Albany, NY 12208, USA. prestos@mail.amc.edu
Abstract:
Antiretroviral drug exposure has been linked to both antiviral efficacy and the development of toxicity and further research in this area is ongoing and necessary. Use of these data may have important implications for TDM of HAART regimens in clinical practice. TDM, in conjunction with an assessment of the patient's viral resistance in the form of an IQ, needs to be examined and validated in large clinical trials.
Related Concept Videos
Retrovirus Life Cycles
Pharmacokinetics: Drug–Drug Interactions
Inhibitors of Virion Maturation and Assembly
Inhibitors of Viral Protein Synthesis
Measurement of Bioavailability: Pharmacodynamic Methods
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
